share_log

Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%), etc.

SEC announcement ·  Jun 7, 2023 21:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more